Fulminant capillary leak syndrome in a patient with systemic sclerosis treated with imatinib mesylate

Rheumatology (Oxford). 2016 Oct;55(10):1916-8. doi: 10.1093/rheumatology/kew245. Epub 2016 Jun 23.
No abstract available

Publication types

  • Case Reports
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use
  • Biopsy
  • Capillary Leak Syndrome / chemically induced*
  • Capillary Leak Syndrome / diagnosis
  • Fatal Outcome
  • Female
  • Humans
  • Imatinib Mesylate / adverse effects*
  • Imatinib Mesylate / therapeutic use
  • Middle Aged
  • Scleroderma, Systemic / drug therapy*

Substances

  • Antineoplastic Agents
  • Imatinib Mesylate